A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of dexmedetomidine as
compared to placebo when used for the sedation of subjects requiring monitored anesthesia
care (MAC).
Phase:
Phase 3
Details
Lead Sponsor:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer